Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR. - Huang JM; Ren RY; Bao Y; Guo JC; Xiang W; Jing XZ; Shi J; Zhang GX; Li L; Tian Y; Kang H; Guo FJ (Frontiers in pharmacology, 2018)